ATE180974T1 - Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen - Google Patents

Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen

Info

Publication number
ATE180974T1
ATE180974T1 AT92909725T AT92909725T ATE180974T1 AT E180974 T1 ATE180974 T1 AT E180974T1 AT 92909725 T AT92909725 T AT 92909725T AT 92909725 T AT92909725 T AT 92909725T AT E180974 T1 ATE180974 T1 AT E180974T1
Authority
AT
Austria
Prior art keywords
small cell
compositions
methods
lung cancer
vasoactive intestinal
Prior art date
Application number
AT92909725T
Other languages
English (en)
Inventor
Terry W Moody
Original Assignee
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ George Washington filed Critical Univ George Washington
Application granted granted Critical
Publication of ATE180974T1 publication Critical patent/ATE180974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92909725T 1991-03-29 1992-03-26 Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen ATE180974T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/676,987 US5273963A (en) 1991-03-29 1991-03-29 Compositions and methods for treating small cell and nonsmall cell lung cancers

Publications (1)

Publication Number Publication Date
ATE180974T1 true ATE180974T1 (de) 1999-06-15

Family

ID=24716841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92909725T ATE180974T1 (de) 1991-03-29 1992-03-26 Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen

Country Status (11)

Country Link
US (2) US5273963A (de)
EP (1) EP0578738B1 (de)
JP (1) JP3081643B2 (de)
AT (1) ATE180974T1 (de)
AU (1) AU653598B2 (de)
CA (1) CA2106978C (de)
DE (1) DE69229394T2 (de)
ES (1) ES2136084T3 (de)
HK (1) HK1012989A1 (de)
SG (1) SG66274A1 (de)
WO (1) WO1992017199A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
TW224053B (de) * 1991-09-13 1994-05-21 Paul B Chretien
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5565424A (en) * 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
JP3853384B2 (ja) * 1994-09-09 2006-12-06 株式会社三菱化学ヤトロン 抗サイモシンα１モノクローナル抗体産生ハイブリドーマ
CA2232086A1 (en) * 1995-09-15 1997-04-03 Samir Chachoua Method for the identification and therapeutic use of disease-associated organisms, elements and forces
US5744363A (en) * 1996-08-16 1998-04-28 National Institute Of Immunology Method for establishing a tumor-cell line by preparing single-cell suspension of tumor cells from tumor biopsies
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6462017B1 (en) 2000-05-01 2002-10-08 Sciclone Pharmaceuticals, Inc. Method of reducing side effects of chemotherapy in cancer patients
US6767891B2 (en) * 2000-06-14 2004-07-27 Chanda Zaveri Peptides with wound healing activity
PL374537A1 (en) * 2002-06-28 2005-10-31 Sciclone Pharmaceuticals, Inc. Method of up-regulating tumor antigen expression using thymalfasin
EP1583550A2 (de) * 2003-01-16 2005-10-12 D. Collen Research Foundation vzw Behandlung von thrombozytopenie mit hilfe von pacap-inhibitoren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4082737A (en) * 1977-02-22 1978-04-04 Hoffmann-La Roche Inc. Stabilized thymosin composition and method
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4560676A (en) * 1980-04-07 1985-12-24 The Rockefeller University N.sup.α -desacetylthymosinα1 and process
US5217953A (en) * 1990-11-30 1993-06-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Vasoactive intestinal peptide antagonist
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物

Also Published As

Publication number Publication date
AU1694492A (en) 1992-11-02
EP0578738A4 (de) 1994-11-02
AU653598B2 (en) 1994-10-06
EP0578738A1 (de) 1994-01-19
DE69229394D1 (de) 1999-07-15
HK1012989A1 (en) 1999-08-13
CA2106978C (en) 2008-06-03
JPH06506225A (ja) 1994-07-14
US5721211A (en) 1998-02-24
CA2106978A1 (en) 1992-09-30
JP3081643B2 (ja) 2000-08-28
SG66274A1 (en) 1999-07-20
EP0578738B1 (de) 1999-06-09
US5273963A (en) 1993-12-28
DE69229394T2 (de) 2000-01-05
ES2136084T3 (es) 1999-11-16
WO1992017199A1 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
ATE180974T1 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen
SE8900247D0 (sv) Amphiregulin: a novel bifunctional growth modulating glycoprotein
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
MX9700553A (es) Anticuerpos que activan un receptor de eritropoyetina.
TR199901971T2 (xx) Bir resept�re ba�lanan peptidler ve bile�ikler.
EP1746160A3 (de) Hepatozyt-Wachstumsfaktor-Rezeptor-Antagonisten und deren Anwendung
DK0912738T3 (da) Antigen-bindende-fragmenter der specifikt detekterer cancerceller, nukleotider der koder fragmenterne og anvendelse deraf til profylakse og detektion af cancere
ATE161582T1 (de) Monoklonale antikörper der maus
BR9914116A (pt) Composições e métodos para imunoterapia especìfica de wt1
ATE483733T1 (de) Hochaffine humane antikörper gegen tumorantigene
WO2001008636A8 (en) Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
AU2003217055A1 (en) Protein for use in hypoxia related conditions
DE69129989D1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
ATE480566T1 (de) Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
DE59209650D1 (de) Monoklonale antikörper gegen c-kit
ATE213507T1 (de) Methode zur bindung von material an das beta- amyloid-peptid
ATE407698T1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ES8800274A1 (es) Un procedimiento para la preparacion de un polipeptido-c-terminal p21ras
MY105946A (en) Antagonists of gm-csf derived from the carboxyl terminus.
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
WO1999002545A3 (en) Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
IL187595A (en) Pharmaceutical preparation containing monoclonal antibody - tumors and production
EP1073683A4 (de) G-csf-rezeptoragonist-antikörper und methode zu ihrer isolierung mittels durchmusterung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties